172@29@17@141!~!172@29@0@53!~!|news|india|coronavirus-pandemic-ge-power-india-resumes-operations-at-durgapur-plant-5215021.html?utm_source=MC_OpeninApp!~!news|moneycontrol|com!~!|controller|infinite_scroll_article.php!~!is_mobile=false
Moneycontrol
Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsIndia
Last Updated : May 02, 2020 05:21 PM IST | Source: PTI

Coronavirus pandemic | GE Power India resumes operations at Durgapur plant

The company is taking all precautions, safety and social distancing measures and implementing all applicable guidelines issued by the authorities across its operations and offices for prevention and containment of COVID-19, a BSE filing added.

PTI
Representative Image
Representative Image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

GE Power India on Saturday said it has resumed production at its Durgapur plant in West Bengal. The company had suspended operations temporarily at its facilities located at Durgapur, West Bengal, and Noida, Uttar Pradesh, due to the lockdown imposed by the government in March to contain COVID-19 pandemic.

"We would like to inform that, from today i.e. 02 May 2020, after obtaining requisite approvals/permissions from the competent authority/ies the Company has resumed its manufacturing operations at its Durgapur factory, to the extent permitted by the local administration/competent authority," a BSE filing said.

Coronavirus India LIVE Updates

Close

The company is taking all precautions, safety and social distancing measures and implementing all applicable guidelines issued by the authorities across its operations and offices for prevention and containment of COVID-19, it added.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"We will continue to follow the recommendations/advisories as may be issued from time to time by the  relevant authorities," it said.

Follow our full coverage of the coronavirus pandemic here.
First Published on May 2, 2020 05:15 pm
Sections